$NUMD
Nu-Med Plus Inc

2021 Q3 Form 10-Q Financial Statement

#000154812321000097 Filed on August 16, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $115.7K $250.6K $901.4K
YoY Change -74.1% -72.2% 275.02%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.650K $1.417K $3.048K
YoY Change -12.83% -53.51% -10.88%
% of Gross Profit
Operating Expenses $118.4K $252.0K $904.4K
YoY Change -73.68% -72.14% 270.99%
Operating Profit -$118.4K -$252.0K -$904.4K
YoY Change -72.14%
Interest Expense $0.00 $4.021K
YoY Change -100.0% -191.39%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$118.4K -$242.6K -$908.5K
YoY Change -73.92% -73.29% 266.05%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$118.4K -$242.6K -$908.5K
YoY Change -73.92% -73.3% 266.05%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share -$1.492K $0.00 -$19.19K
COMMON SHARES
Basic Shares Outstanding 79.35M shares 79.35M shares 47.34M shares
Diluted Shares Outstanding 79.35M shares 79.35M shares

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.84K $72.83K $6.110K
YoY Change 1.08% 1091.98% -61.06%
Cash & Equivalents $31.84K $72.83K $6.106K
Short-Term Investments
Other Short-Term Assets $2.830K $6.740K $826.7K
YoY Change -99.52% -99.18% 14957.56%
Inventory
Prepaid Expenses $6.738K
Receivables
Other Receivables
Total Short-Term Assets $34.67K $79.57K $832.8K
YoY Change -94.45% -90.45% 3833.68%
LONG-TERM ASSETS
Property, Plant & Equipment $4.916K $7.566K $19.48K
YoY Change -80.54% -61.16% -38.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $16.57K $9.561K $19.48K
YoY Change -34.38% -50.92% -38.39%
TOTAL ASSETS
Total Short-Term Assets $34.67K $79.57K $832.8K
Total Long-Term Assets $16.57K $9.561K $19.48K
Total Assets $51.24K $89.13K $852.2K
YoY Change -92.11% -89.54% 1514.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $38.54K $6.744K $80.16K
YoY Change -23.09% -91.59% 1336.56%
Accrued Expenses $82.71K $56.04K $121.0K
YoY Change -40.19% -53.69% 2.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $230.1K
YoY Change -100.0% -100.0% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $121.3K $90.78K $431.3K
YoY Change -71.03% -78.95% 19.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $9.380K
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $9.380K
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $121.3K $90.78K $431.3K
Total Long-Term Liabilities $0.00 $0.00 $9.380K
Total Liabilities $121.3K $90.78K $440.7K
YoY Change -71.66% -79.4% 22.39%
SHAREHOLDERS EQUITY
Retained Earnings -$9.339M
YoY Change
Common Stock $79.35K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$70.02K -$1.651K $411.6K
YoY Change
Total Liabilities & Shareholders Equity $51.24K $89.13K $852.2K
YoY Change -92.11% -89.54% 1514.4%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$118.4K -$242.6K -$908.5K
YoY Change -73.92% -73.3% 266.05%
Depreciation, Depletion And Amortization $2.650K $1.417K $3.048K
YoY Change -12.83% -53.51% -10.88%
Cash From Operating Activities -$40.99K -$66.44K -$147.3K
YoY Change -59.42% -54.91% 22.26%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 135.1K
YoY Change -100.0% -100.0% 19.64%
NET CHANGE
Cash From Operating Activities -40.99K -66.44K -147.3K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 0.000 0.000 135.1K
Net Change In Cash -40.99K -66.44K -12.23K
YoY Change -261.38% 443.25% 61.35%
FREE CASH FLOW
Cash From Operating Activities -$40.99K -$66.44K -$147.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001543637
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
79348469 shares
CY2021Q2 us-gaap Cash
Cash
72831 USD
CY2020Q4 us-gaap Cash
Cash
188506 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6738 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
349017 USD
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54808
dei Entity Registrant Name
EntityRegistrantName
NU-MED PLUS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-3672530
dei Entity Address Address Line1
EntityAddressAddressLine1
455 East 500 South, Suite 203
dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84111
dei City Area Code
CityAreaCode
801
dei Local Phone Number
LocalPhoneNumber
746-3570
CY2020Q4 us-gaap Assets
Assets
557135 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
26048 USD
CY2020Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
20000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26019 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
7981 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
80048 USD
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
9384 USD
CY2020Q4 us-gaap Liabilities
Liabilities
89432 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79348469 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51028469 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
51029 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8431593 USD
CY2020Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
724314 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8739233 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
467703 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
557135 USD
CY2020Q2 us-gaap Revenues
Revenues
USD
us-gaap Revenues
Revenues
USD
us-gaap Revenues
Revenues
USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11631 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1995 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7981 USD
CY2021Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
9561 USD
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
19612 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
79569 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
537523 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7566 USD
CY2021Q2 us-gaap Assets
Assets
89130 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6744 USD
CY2021Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
26000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
56042 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1995 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
90781 USD
CY2021Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
USD
CY2021Q2 us-gaap Liabilities
Liabilities
90781 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79348469 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51028469 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
79349 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9257587 USD
CY2021Q2 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9338587 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1651 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
89130 USD
CY2021Q2 us-gaap Revenues
Revenues
USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5936 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29581 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37985 USD
CY2021Q2 us-gaap Salaries And Wages
SalariesAndWages
67486 USD
CY2021Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
6265 USD
CY2020Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4690 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
12529 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
9379 USD
CY2021Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
170886 USD
CY2021Q2 us-gaap Depreciation
Depreciation
1417 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
251990 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-251990 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
USD
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
9384 USD
CY2021Q2 us-gaap Other Income
OtherIncome
9384 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-242606 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-242606 USD
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79348469 shares
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13770 USD
CY2020Q2 us-gaap Salaries And Wages
SalariesAndWages
503858 USD
us-gaap Salaries And Wages
SalariesAndWages
136972 USD
us-gaap Salaries And Wages
SalariesAndWages
571333 USD
CY2020Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
363269 USD
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
441401 USD
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
428966 USD
CY2020Q2 us-gaap Depreciation
Depreciation
3048 USD
us-gaap Depreciation
Depreciation
4066 USD
us-gaap Depreciation
Depreciation
6096 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
904446 USD
us-gaap Operating Expenses
OperatingExpenses
608738 USD
us-gaap Operating Expenses
OperatingExpenses
1053759 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-904446 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-608738 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1053759 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
4021 USD
us-gaap Interest Expense
InterestExpense
USD
us-gaap Interest Expense
InterestExpense
8042 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
9384 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
CY2020Q2 us-gaap Other Income
OtherIncome
-4021 USD
us-gaap Other Income
OtherIncome
9384 USD
us-gaap Other Income
OtherIncome
-8042 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-908467 USD
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-599354 USD
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-1061801 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-908467 USD
us-gaap Net Income Loss
NetIncomeLoss
-599354 USD
us-gaap Net Income Loss
NetIncomeLoss
-1061801 USD
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47336288 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79312668 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47352260 shares
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-367327 USD
CY2020Q2 numd Stock Subscription Payable Cash
StockSubscriptionPayableCash
125731 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
467703 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
30000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5049 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-145675 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-242527 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
232170 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-6248 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-19304 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
18229 USD
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
6000 USD
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
8026 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
30023 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
50000 USD
CY2021Q1 numd Common Stock Issued Under Subscription Value
CommonStockIssuedUnderSubscriptionValue
USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-356748 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
190955 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
50000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-242606 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1651 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-370432 USD
CY2020Q1 numd Stock Subscription Payable Cash
StockSubscriptionPayableCash
106439 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
50000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-153334 USD
CY2020Q2 numd Common Stock Issued Under Subscription Value
CommonStockIssuedUnderSubscriptionValue
USD
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
10000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
940500 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
611150 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-908467 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
411587 USD
us-gaap Net Income Loss
NetIncomeLoss
-599354 USD
us-gaap Net Income Loss
NetIncomeLoss
-1061801 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4065 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6096 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
9384 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
5986 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
6248 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
100000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
661150 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-342279 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-975 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5986 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
9384 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
241554 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-115675 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-973 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
188506 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7079 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72831 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6106 USD
us-gaap Interest Paid
InterestPaid
USD
us-gaap Interest Paid
InterestPaid
USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
us-gaap Stock Issued1
StockIssued1
724314 USD
us-gaap Stock Issued1
StockIssued1
676711 USD
numd Common Stock Issued For Services Performed
CommonStockIssuedForServicesPerformed
100000 USD
numd Common Stock Issued For Services Performed
CommonStockIssuedForServicesPerformed
661160 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:10pt; margin-bottom:0pt; "> c. Estimates </p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:10pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p>
us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
0 shares
CY2021Q2 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
0 shares
us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
84000 shares
CY2020Q2 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
84000 shares
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-242606 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-908467 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-599354 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1061801 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79348469 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47336288 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79312668 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47352260 shares
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
numd Dilutive Shares
DilutiveShares
0 shares
numd Dilutive Shares
DilutiveShares
35175000 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:10pt; margin-bottom:0pt; "> h. Concentrations and Credit Risk - The Company has relied on a small group of investors to fund its operations. If this group becomes unable or unwilling to provide additional funding, the Company may be unable to remain in business or to execute on its business plan. </p>
numd Planned Expenditures
PlannedExpenditures
1200000 USD
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
1545000 shares
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
90368 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
90368 USD
CY2021Q2 numd Accumulated Depreciation
AccumulatedDepreciation
-82802 USD
CY2020Q4 numd Accumulated Depreciation
AccumulatedDepreciation
-78737 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7566 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11631 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4065 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6096 USD
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1000000 shares
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
10000 USD
numd Merrell Stock Compensation
MerrellStockCompensation
2000000 shares
numd Merrell Stock Compensation Value
MerrellStockCompensationValue
500000 USD
CY2018Q3 numd Waterside Capital Adviserincentiveshares
WatersideCapitalAdviserincentiveshares
2000000 shares
numd Merrell Stock Compensation Amount
MerrellStockCompensationAmount
100000 USD
numd Merrell Stock Compensation Amount
MerrellStockCompensationAmount
100000 USD
numd Merrell Additional Stock Compensation
MerrellAdditionalStockCompensation
500000 shares
numd Merrell Additional Stock Compensation Amount
MerrellAdditionalStockCompensationAmount
435000 USD
CY2021Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
0 USD
CY2020Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
21000 USD
us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
0 shares
CY2020 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
84000 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
120000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
30000 USD
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
200000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000 USD
numd N1545000 Shares Issued For Services
N1545000SharesIssuedForServices
1601650 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
940500 USD
numd Shares Issued For Services Amount Paid
SharesIssuedForServicesAmountPaid
245899 USD
numd Scs Total Settlement Shares
ScsTotalSettlementShares
28000000 shares
CY2012Q4 numd Scs Convertible Promissory Note Principal
ScsConvertiblePromissoryNotePrincipal
100000 USD
CY2021Q2 numd Scs Convertible Promissory Note Interest Rate
ScsConvertiblePromissoryNoteInterestRate
0.055 pure
CY2021Q2 numd Scs Convertible Promissory Note Conversion Price
ScsConvertiblePromissoryNoteConversionPrice
0.01
numd N130100 Convertible Promissory Note Interest Rate
N130100ConvertiblePromissoryNoteInterestRate
0.08 pure
numd N130100 Convertible Promissory Note Conversion Price
N130100ConvertiblePromissoryNoteConversionPrice
0.01
CY2017Q1 numd Monthly Office Lease Payment
MonthlyOfficeLeasePayment
950 USD
numd Monthly Office Lease Payment
MonthlyOfficeLeasePayment
978 USD
numd Monthly Office Lease Payment
MonthlyOfficeLeasePayment
1008 USD
numd Monthly Office Lease Payment
MonthlyOfficeLeasePayment
1038 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
5986 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1995 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1995 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
6248 USD
CY2021Q2 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
2076 USD
CY2020 numd Gill Shares Received In Consulting Agreement
GillSharesReceivedInConsultingAgreement
500000 shares
CY2020 numd Kristensen Shares Received In Consulting Agreement
KristensenSharesReceivedInConsultingAgreement
100000 shares
CY2020 numd Gill And Kristensen Consulting Shares Value Total
GillAndKristensenConsultingSharesValueTotal
565500 USD
numd Hanover Compensation Monthly Payment
HanoverCompensationMonthlyPayment
3500 USD
numd Hanover Total Compensation Shares
HanoverTotalCompensationShares
750000 shares
numd Hanover Tranche Compensation Shares
HanoverTrancheCompensationShares
187500 shares
numd Hanover Total Value
HanoverTotalValue
375000 USD

Files In Submission

Name View Source Status
0001548123-21-000097-index-headers.html Edgar Link pending
0001548123-21-000097-index.html Edgar Link pending
0001548123-21-000097.txt Edgar Link pending
0001548123-21-000097-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
numd-20210630.xsd Edgar Link pending
numd-20210630_cal.xml Edgar Link unprocessable
numd-20210630_def.xml Edgar Link unprocessable
numd-20210630_lab.xml Edgar Link unprocessable
numd-20210630_pre.xml Edgar Link unprocessable
numd10q0621.htm Edgar Link pending
numd10q0621_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending